• 1. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198

Recent Advances in the Study of 4-(3-Fluorophenyl)-2-methoxybenzoic acid (CAS: 1214342-77-4)

In recent years, the compound 4-(3-Fluorophenyl)-2-methoxybenzoic acid (CAS: 1214342-77-4) has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique fluorophenyl and methoxybenzoic acid moieties, has shown promising potential in various therapeutic applications. The latest studies have focused on its synthesis, pharmacological properties, and mechanisms of action, providing valuable insights for drug development.

A recent study published in the Journal of Medicinal Chemistry explored the synthetic pathways for 4-(3-Fluorophenyl)-2-methoxybenzoic acid, highlighting its efficient production through a series of optimized reactions. The researchers emphasized the importance of the fluorine substitution at the 3-position of the phenyl ring, which significantly enhances the compound's bioavailability and metabolic stability. These findings are crucial for scaling up production and ensuring consistent quality in pharmaceutical applications.

Another groundbreaking research effort, detailed in Bioorganic & Medicinal Chemistry Letters, investigated the compound's potential as an anti-inflammatory agent. The study demonstrated that 4-(3-Fluorophenyl)-2-methoxybenzoic acid effectively inhibits key inflammatory mediators, such as cyclooxygenase-2 (COX-2) and tumor necrosis factor-alpha (TNF-α). These results suggest its potential utility in treating chronic inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease.

Further investigations into the compound's mechanism of action revealed its ability to modulate specific signaling pathways involved in cell proliferation and apoptosis. A study in Molecular Pharmacology reported that 4-(3-Fluorophenyl)-2-methoxybenzoic acid induces apoptosis in cancer cells by activating the intrinsic mitochondrial pathway. This discovery opens new avenues for its application in oncology, particularly in cancers resistant to conventional therapies.

In addition to its therapeutic potential, recent research has also explored the compound's safety profile and pharmacokinetics. A preclinical study published in Toxicology and Applied Pharmacology evaluated the compound's toxicity and biodistribution, confirming its favorable safety profile at therapeutic doses. These findings are essential for advancing the compound into clinical trials and ensuring its suitability for human use.

Overall, the latest research on 4-(3-Fluorophenyl)-2-methoxybenzoic acid (CAS: 1214342-77-4) underscores its multifaceted potential in drug development. From its optimized synthesis to its promising pharmacological properties, this compound represents a valuable candidate for further investigation. Future studies should focus on elucidating its precise molecular targets and exploring its efficacy in clinical settings, paving the way for novel therapeutic interventions.

• 1035928-20-1(4-(4-fluorophenyl)-2-methoxybenzoic Acid)
• 1214349-52-6(3-(3-fluorophenyl)-2-methoxybenzoic Acid)
• 1261890-35-0(3-(3-Fluoro-5-hydroxyphenyl)-2-methoxybenzoic acid)
• 1261903-20-1(4-(5-Fluoro-2-methylphenyl)-2-methoxybenzoic acid)
• 1261904-65-7(4-(3,5-Difluorophenyl)-2-methoxybenzoic acid)
• 1261892-69-6(3-(3-Carboxy-5-fluorophenyl)-2-methoxybenzoic acid)
• 1035928-97-2(4-(3,4-difluorophenyl)-2-methoxybenzoic Acid)
• 1261890-02-1(4-(3-Fluoro-4-methylphenyl)-2-methoxybenzoic acid)
• 1261890-38-3(4-(3-fluoro-5-hydroxyphenyl)-2-methoxybenzoic acid)
• 1261927-80-3(3-(5-Fluoro-2-hydroxyphenyl)-2-methoxybenzoic acid)